IN CHILDHOOD B-CELL NON HODGKIN'S LYMPHOMA (B-NHL) AND MATURE B-CELL ACUTE LEUKEMIA (B-AL) WITH CNS DISEASE AT DIAGNOSIS, PATIENTS WITH BLASTS IN CSF ARE AT HIGHER RISK OF EVENT

被引：0
|
作者：
Minard-Colin, V. [1 ]
Auperin, A. [1 ]
Leverger, G. [2 ]
Schmitt, C. [3 ]
Aladjidi, N. [4 ]
Michon, J. [5 ]
Patte, C. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Hop Armand Trousseau, Paris, France
[3] Hop Enfants, Vandoeuvrelesnancy, France
[4] Hop Enfants, Bordeaux, France
[5] Inst Curie, Paris, France
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Biallelic inactivation of TP53 is associated with an increased risk of relapse in paediatric B-cell Non-Hodgkin lymphoma (B-NHL)
    Newman, Alexander M.
    Zaka, Masood
    Zhou, Peixun
    Erhorn, Amy
    Barnard, Amy
    Crossland, Rachel E.
    Wilkinson, Sarah
    Enshaei, Amir
    Taj, Mary
    Wood, Katrina
    Televantou, Despina
    Turner, Suzanne D.
    Burke, Amos
    Harrison, Christine J.
    Bomken, Simon
    Bacon, Chris M.
    Rand, Vikki
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 60 - 60
  • [32] CHILDHOOD B-CELL NON-HODGKIN LYMPHOMA (NHL) IN ISRAEL - A 10 YEAR EXPERIENCE
    KAPLINSKY, C
    MOR, C
    COHEN, IJ
    STARK, B
    VOGEL, R
    UMIEL, T
    ZAIZOV, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 337 - 337
  • [33] Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL)
    Perea, G
    Altés, A
    Bellido, M
    Aventín, A
    Bordes, R
    Ayats, R
    Remacha, AF
    Espinosa, I
    Briones, J
    Sierra, J
    Nomdedéu, JF
    HISTOPATHOLOGY, 2004, 45 (03) : 268 - 274
  • [34] Reduced Burden of Therapy in Intermediate Risk Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): Preliminary Results of the Reduced Burden of Oncologic Therapy (REBOOT) Trial
    Barth, M. J.
    Goldman, S. C.
    Oesterheld, J.
    Heym, K.
    Harrison, L.
    Nickerson, B.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S36 - S36
  • [35] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    BLOOD, 2007, 110 (11) : 387A - 387A
  • [37] Higher frequency of HCV in patients with non-Hodgkin lymphoma: Is it enough to suggest an association with B-cell NHL?
    Iannitto, E
    Barbera, V
    Gambino, R
    Ammatuna, E
    Montalto, G
    Di Stefano, R
    HEPATOLOGY, 2003, 37 (02) : 481 - 482
  • [38] A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).
    Ando, Kiyoshi
    Ogura, Michinori
    Suzuki, Tatsuya
    Ishizawa, Kenichi
    Oh, Sung Yong
    Kim, Won Seog
    Tanaka, Yoshinobu
    Shimamoto, Takashi
    Tobinai, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [39] Advances in the Diagnosis and Treatment of Childhood and Adolescent B-Cell Non-Hodgkin Lymphoma
    El-Mallawany, Nader Kim
    Cairo, Mitchell S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (02) : 113 - 123
  • [40] Radioimmunotherapy of B-cell non-Hodgkin's lymphoma
    Postema, EJ
    Boerman, OC
    Oyen, WJG
    Raemaekers, JMM
    Corstens, FHM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (11) : 1725 - 1735
12345